The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,872,220 in first-year total cost, median $403,686.
Most frequent study sections
- Translational Immuno-oncology Study Section[TIO]7
- Cellular Immunotherapy of Cancer Study Section[CIC]2
- Cancer Prevention Study Section[CPSS]1
- Radiation Therapeutics and Biology Study Section[RTB]1
Most frequent institutions
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- BROAD INSTITUTE, INC.1
- CASE WESTERN RESERVE UNIVERSITY1
- JOHNS HOPKINS UNIVERSITY1
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Engineering diverse commensal skin bacteria for targeted immunotherapy1R21CA293614-01A1 | CHEN, YIYIN ERINJOHNSTON, CHRISTOPHER D | BROAD INSTITUTE, INC., MA | $443,564 | TIO |
| 2025 | Salmonella derived nanoparticles for cancer immunotherapy1R21DE034547-01 | HUNG, CHIEN-FU | JOHNS HOPKINS UNIVERSITY, MD | $204,688 | TIO |
| 2024 | Health-associated oral bacteria as anti-cancer and immunomodulatory agents in oral cancer1R21DE033458-01A1 | AL-HEBSHI, NEZARWHELAN, KELLY A | TEMPLE UNIV OF THE COMMONWEALTH, PA | $469,830 | TIO |
| 2024 | Modulating Intratumoral Immune Composition to Enhance Immunotherapy1R21CA293969-01 | MANUEL, EDWIN | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $457,683 | CIC |
| 2024 | An engineered bacterial reporter gene fusion for radiotheranostics1R21CA287211-01A1 | CHEAL, SARAH MARIEFORBES, NEIL S. | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $434,903 | RTB |
| 2024 | Engineered bacterial in situ vaccines against oral cancer.1R21DE034543-01 | TABOR, JEFFREY JAYVEISEH, OMIDYOUNG, SIMON | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $434,170 | TIO |
| 2024 | Phage-based therapeutic gene delivery targeting multiple compartments in solid tumors1R21CA283355-01A1 | ARAP, WADIHPASQUALINI, RENATA | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $403,686 | TIO |
| 2024 | Salmonella as a vector for delivery of oncolytic viruses to hepatocellular carcinoma1R21CA293765-01 | FORBES, NEIL S. | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $402,147 | TIO |
| 2024 | Roles of gut-breast axis in breast pathophysiology1R21CA288449-01 | FURUTA, SAORI | CASE WESTERN RESERVE UNIVERSITY, OH | $225,803 | CPSS |
| 2024 | A novel gene-based immunotherapy inducing melanoma destruction1R21CA283583-01A1 | MICHAEL, KATJA | UNIVERSITY OF TEXAS EL PASO, TX | $174,151 | TIO |
| 2023 | Optimization of CAR-Bacteria for Oral Cancer1R21CA280794-01 | BUI, JACK DCHANG, GEOFFREY AHASTY, JEFF M | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $221,595 | CIC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.